Search results for: pediatric rheumatology

Interfering with Interferon: Experts Discuss IFN Signaling & IFN Inhibition Treatment Possibilities

Mary Beth Nierengarten | January 25, 2021

NIH investigators describe key features and genetic causes of Mendelian interferonopathies, & treatment approaches that may indicate the efficacy of IFN inhibition.

Advancing the ACR’s Legislative Priorities in 2021

Zach Wallace, MD, MSc | January 11, 2021

With a new Congress and many new legislators in key leadership positions, your support today will help RheumPAC start the year off strong.

Evaluation & Treatment of Systemic Sclerosis-ILD in the New Decade

Thomas R. Collins | December 17, 2020

ACR Convergence panelists discussed how to monitor SSc-ILD patients for ILD severity & the brightening prospects for therapy.

COVID-19 Perspectives Shared in ACR Convergence Opening Session

Thomas R. Collins | November 23, 2020

ACR CONVERGENCE 2020—Eric Rubin, MD, PhD, took over as editor in chief of the New England Journal of Medicine in September 2019, just a few months before COVID-19 began taking over the world. Since then, Dr. Rubin’s perspective on the pandemic has been unlike that of any other person: He has led reviews of a…

The New Guidance Subcommittee Gives ACR More Document Flexibility

Ruth Jessen Hickman, MD | November 12, 2020

The ACR publishes multiple types of documents to provide guidance for its members, but some potentially beneficial topics have not fit neatly into existing production pathways. To answer the need, the ACR has formed a Guidance Subcommittee to the Quality of Care (QOC) Committee. This will allow the ACR to adapt more nimbly, when appropriate,…

ACR President Ellen Gravallese, MD, Says Farewell

Ellen M. Gravallese, MD | November 12, 2020

To the Members of the American College of Rheumatology, I had the honor and privilege of becoming the ACR’s 83rd president during the annual meeting in Atlanta in November 2019. My aspirations for the year were ambitious, filled with hopes of leading the ACR and the field of rheumatology forward in many new and bold…

ACR Convergence 2020: COVID-19 Hyper-Inflammation in Kids

Jason Liebowitz, MD, FACR | November 9, 2020

ACR CONVERGENCE 2020—Among the many ways in which the COVID-19 pandemic has changed the face of modern medicine is the emergence of multisystem inflammatory syndrome in children (MIS-C), a rare but serious condition that shares many features of Kawasaki disease (KD). With this topic in mind, leading pediatric experts from around the world came together…

Rheum After 5: Polly Ferguson, MD, Is Perfecting Her Pottery Skills

Carol Patton | November 5, 2020

After a busy day in rheumatology, Polly Ferguson, MD, gets creative at a local arts center, making beautiful pottery pieces, a skill she has wanted to develop for nearly 30 years.

Outpatient Medicine in the Post-COVID-19 Era of Telemedicine

Richard L. Allman, MD, MS, FACP, FACR | October 19, 2020

Our hospitals have had their finest hour in the care of acutely ill inpatients during the COVID-19 pandemic, including dealing with allocation decisions fairly and transparently, maximizing good outcomes and remaining cognizant of the enduring ethics of healthcare. The honorable traditions of self-effacing conduct and acceptance of some level of personal risk by healthcare professionals…

Case Report: A 40-Year-Old Man with Vasculitic Neuropathy

Martin Garber, DO, & David Fivenson, MD | October 19, 2020

Ironically, chronic exposure to minocycline has also been associated with a variety of autoimmune syndromes, including drug-induced lupus, autoimmune hepatitis, serum sickness and vasculitis.1 Minocycline is associated with an 8.5-fold increased risk of drug-induced lupus.2 Minocycline and nitrofurantoin are implicated in 90% of cases of drug-induced autoimmune hepatitis.3 Minocycline-induced vasculitis is much less common and,…